CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in RGNX — REGENXBIO Inc.
CIK 884546
SAN FRANCISCO, CA
Position in RGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,273,236
-$2,363,802 QoQ
Shares Held
390,601
-0.2% QoQ
Ownership
0.756%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,184,692,793 across 287 Biotechnology names. RGNX ranks #153 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in RGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,273,236 | 390,601 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,637,038 | 391,461 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,782,684 | 391,988 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,181,399 | 387,503 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,620,825 | 366,549 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $2,703,412 | 349,730 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,382,082 | 417,739 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,454,002 | 380,684 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $7,239,968 | 343,615 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,877,745 | 327,451 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,362,141 | 325,768 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,960,578 | 298,178 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,476,468 | 289,607 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $6,522,019 | 287,567 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,369,424 | 278,828 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,777,605 | 274,397 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,535,022 | 287,286 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,425,382 | 288,238 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $11,934,624 | 284,700 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $10,304,146 | 265,229 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,384,988 | 245,822 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $9,366,567 | 206,494 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,610,474 | 203,869 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $7,948,540 | 215,817 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $6,571,844 | 202,960 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||